NCT06669130View on ClinicalTrials.gov

Xiangtong TM Full Degradation Sinus Drug Stent System Prospective, Open, Single-center, Randomized Controlled Clinical Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2027

Conditions
Chronic Rhinosinusitis (CRS)
Interventions
DEVICE

Xiangtong TM full degradation sinus drug stent system

use Xiangtong TM full degradation sinus drug stent system to deliver drugs into sinus

DEVICE

nasopore

use nasopore to protect the post-operative sinus

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER